Bronchiolitis obliterans and lung transplantation: Evidence for an infectious etiology

Seminars in Respiratory Infections

Volumn 17, Issue 4, 2002, Pages 310-314

  Husain, Shahid ^a,b   Singh, Nina ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GANCICLOVIR; HYPERIMMUNE GLOBULIN;

BRONCHIOLITIS; CELL PROLIFERATION; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FIBROBLAST; GRAFT REJECTION; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LUNG TRANSPLANTATION; NONHUMAN; PARAINFLUENZA VIRUS; PATHOGENESIS; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK FACTOR; SURVIVAL; T LYMPHOCYTE;

BRONCHIOLITIS OBLITERANS; HUMANS; LUNG TRANSPLANTATION; RISK FACTORS;

EID: 0036900552     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.36442     Document Type: Review

References (40)

1. Hosenpud JD, Bennett LE, Berkeley M, et al: ISHLT registry report 2001. The registry of the international society for heart and lung transplantation: Eighteenth official report. J Heart Lung Transplant 20:805-815, 2001
2. Yousem SA, Berry GJ, Cagle PT. et al: Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group. J Heart Lung Transplant 15:1-15, 1996
3. Estenne M, Maurer J, Boehler A, et al: Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 21:297-310, 2002
4. Boehler A, Estenne M: Obliterative bronchiolitis after lung transplantation. Curr Opin Pulm Med 6:133-139, 2000
5. Bando K, Konishi H, Yousem S, et al: Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management. J Thorac Cardiovasc Surg 110:4-14, 1995
6. Girgis R, Tu I, Berry G, et al: Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 15:1200-1208, 1996
7. Husain A, Siddiqui M, Holmes E, et al: Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159:829-833, 1999
8. Schulman L, Weinberg A, McGregor C, et al: Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 163:437-442, 2001
9. Heng D, Sharples L, McNeil K, et al: Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17:1255-1263, 1998
10. Reichenspurner H, Girgis RE, Robbins RC, et al: Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 60:1845-1853, 1995
11. Scott JP, Higenbottam TW, Clelland CA, et al: Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 9:510-515, 1990
12. Theodore J, Starnes VA, Lewiston NJ: Obliterative bronchiolitis. Clin Chest Med 11:309-321, 1990
13. Fryd DS, Peterson PK, Ferguson RM, et al: Cytomegalovirus as a risk factor in renal transplantation. Transplantation 30:436-439, 1980
14. O'Grady JG, Alexander GJ, Sutherland S, et al: Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 2:302-305, 1988
15. Grattan MT, Moreno-Cabral CE, Starnes VA, et al: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566, 1989
16. Grundy JE, Ayles HM, McKeating JA, et al: Enhancement of class I HLA antigen expression by cytomegalovirus: Role in amplification of virus infection. J Med Virol 25:483-495, 1988
17. Zeevi A, Uknis ME, Spichty KJ, et al: Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients. Transplantation 54:635-639, 1992
18. Ibrahim A, Dominguez M, Yacoub M: Primary human adult lung epithelial cells in vitro: Response to interferon-gamma and cytomegalovirus. Immunology 79:119-124, 1993
19. Keenan RJ, Lega ME, Dummer JS, et al: Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51:433-438, 1991
20. Ettinger N, Bailey T, Trulock E, et al: Cytomegalovirus and pneumonitis. Am Rev Respir Dis 147:1017-1023, 1993
21. Smith M, Sundaresan S, Mohanakumar T, et al: Effect on development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 116:820, 1998
22. El-Gamel A, Sim E, Hasleton P, et al: Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. Transplant 11:828-837, 1999
23. Keller C, Cagle P, Brown R, et al: Bronchiolitis obliterans in recipients of single, double and heart-lung transplantation. Chest 107:973-980, 1995
24. Sundaresan S, Monhanakumar T, Smith MA, et al: HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65:648-653, 1998
25. Duncan S, Paradis I, Yousem S, et al: Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 146:1419-1425, 1992
26. Kroshus T, Kshettry V, Savik K, et al: Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114:195-202, 1997
27. Soghikian M, Valentine V, Berry G, et al: Impact of gancyclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 15:881-887, 1996
28. Speich R, Thurnheer R, Gaspert A, et al: Efficacy and cost effectiveness of oral gancyclovir in the prevention of cytomegalovirus disease after lung transplantation. Transplantation 67:315-320, 1999
29. Kruger R, Shannon W, Arena M, et al: The impact of gancyclovir-resistant cytomegalovirus after lung transplantation. Transplantation 68:1272-1279, 1999
30. Reichenspurner H, Soni V, Brazelton T, et al: Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. J Heart Lung Transplant 17:439-451, 1998
31. Koskinen PK, Kallio EA, Bruggeman CA, et al: Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am J Respir Crit Care Med 155:2078-2088, 1997
32. Tikkanen J, Kallio E, Bruggeman C, et al: Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis of immunosuppression in rat tracheal allografts. Am J Respir Crit Care Med 164:672-679, 2001
33. Winter JB, Gouw ASH, Groen M, et al: Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. Transplantation 57:418-422, 1994
34. Hohlfeld J, Niedermeyer J, Hamm H, et al: Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 15:888-894, 1996
35. Everard ML, Swarbrick A, Wrightman M, et al: Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 71:428-432, 1994
36. Stark JM, Godding V, Sedgwick JB, et al: Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol 15:4774-4782, 1996
37. Garantziotis S, Howell D, McAdams H, et al: Influenza pneumonia in lung transplant recipients: Clinical features and association with bronchiolitis obliterans syndrome. Chest 119:1277-1280, 2001
38. Hodges TN, Torres FP, Zamora MR: Treatment of respiratory syncytial viral and parainfluenza lower respiratory tract infection in lung transplant patients. J Heart Lung Transplant 20:170, 2001
39. Gryzan S, Paradis IL, Zeevi A, et al: Unexpectedly high incidence of Pneumocystic carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 137:1268-1274, 1988
40. Norgaard M, Anderson C, Pettersson G: Does bronchial artery revascularization influence results concerning bronchiolitis obliterans and/or obliterative briochiolitis after lung transplantation? Eur J Cardiothorac Surg 14:311-318, 1998